Chinese-made ‘corona vaccine’ hits and kills … Brazil suspends all clinical trials

Entry 2020.11.10 14:25

In Brazil, where clinical trials were underway for the Chinese-made Corona 19 vaccine, a serious side effect was found and testing was stopped. This is because a participant who received the corona vaccine died in the clinical course.

According to Bloomberg News on the 9th (local time), Brazilian health authorities announced that they had suspended the clinical trial of Sinovac’s COVID-19 candidate vaccine on the 29th of last month. Health authorities will decide whether to resume the clinical trial in accordance with the regulations after further investigation.

The number of deaths among clinical trial participants was said to be the leading cause. In response, Sinovac’s Brazilian partner, Dimas Kovas, director of the Bhutantan Institute, argued that “a volunteer who participated in the clinical trial died, but it has nothing to do with the vaccine.” Sinobaek’s side did not give an official response to this issue.

Previously, AstraZeneca and Johnson & Johnson also temporarily suspended after reports of adverse events during clinical trials of COVID-19 vaccine candidates and resumed a few months later. However, the COVID-19 vaccine developed by Chinese companies, including Sinovac, is controversial because it has already vaccinated many Chinese before the end of phase 3 clinical trials.

This incident is expected to raise awareness about vaccines made in China in Brazil and South America. The Chinese government has been conducting large-scale clinical trials with the promise of supplying Corona 19 vaccines in Brazil, Peru, Chile and Argentina, with the aim that the pharmaceutical industry in Latin American countries is relatively behind.

In Brazil, warnings have been continually raised about the use of vaccines made in China. “It must be scientifically proven before it is distributed to the public,” President Zaire Bolsonaru said on social media.

The Nikkei Asian Review noted that Governor Joao Doria, the influential runner in the upcoming presidential elections, is linked to the Chinese capital. China’s Sinobac is reported to be promoting the establishment of a new factory in Sao Paulo, Governor Doria’s ‘pyobat’, and has signed a contract to transfer various vaccine technologies when the Sao Paulo factory is established.